1. Home
  2. NRXP vs HIT Comparison

NRXP vs HIT Comparison

Compare NRXP & HIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NRXP
  • HIT
  • Stock Information
  • Founded
  • NRXP 2015
  • HIT 1964
  • Country
  • NRXP United States
  • HIT United States
  • Employees
  • NRXP N/A
  • HIT N/A
  • Industry
  • NRXP Biotechnology: Pharmaceutical Preparations
  • HIT Specialty Insurers
  • Sector
  • NRXP Health Care
  • HIT Finance
  • Exchange
  • NRXP Nasdaq
  • HIT Nasdaq
  • Market Cap
  • NRXP 32.6M
  • HIT 37.2M
  • IPO Year
  • NRXP N/A
  • HIT 2024
  • Fundamental
  • Price
  • NRXP $3.50
  • HIT $0.80
  • Analyst Decision
  • NRXP Strong Buy
  • HIT Strong Buy
  • Analyst Count
  • NRXP 4
  • HIT 1
  • Target Price
  • NRXP $28.50
  • HIT $2.50
  • AVG Volume (30 Days)
  • NRXP 295.0K
  • HIT 242.7K
  • Earning Date
  • NRXP 08-13-2025
  • HIT 08-15-2025
  • Dividend Yield
  • NRXP N/A
  • HIT N/A
  • EPS Growth
  • NRXP N/A
  • HIT N/A
  • EPS
  • NRXP N/A
  • HIT 0.02
  • Revenue
  • NRXP N/A
  • HIT $22,380,959.00
  • Revenue This Year
  • NRXP N/A
  • HIT $58.79
  • Revenue Next Year
  • NRXP N/A
  • HIT N/A
  • P/E Ratio
  • NRXP N/A
  • HIT $44.99
  • Revenue Growth
  • NRXP N/A
  • HIT 11.24
  • 52 Week Low
  • NRXP $1.10
  • HIT $0.51
  • 52 Week High
  • NRXP $6.01
  • HIT $7.59
  • Technical
  • Relative Strength Index (RSI)
  • NRXP 66.15
  • HIT N/A
  • Support Level
  • NRXP $2.90
  • HIT N/A
  • Resistance Level
  • NRXP $3.61
  • HIT N/A
  • Average True Range (ATR)
  • NRXP 0.28
  • HIT 0.00
  • MACD
  • NRXP -0.03
  • HIT 0.00
  • Stochastic Oscillator
  • NRXP 64.59
  • HIT 0.00

About NRXP NRX Pharmaceuticals Inc.

NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.

About HIT Health In Tech Inc. Class A Common Stock

Health In Tech Inc is an insurance technology platform company. It offers a marketplace that processes in the healthcare industry through vertical integration, process simplification, and automation. The group removed friction and complexities, it streamlined the underwriting, sales, and service process for insurance companies, licensed brokers, and TPAs.

Share on Social Networks: